pracinostat
Phase 3- Indications
- Acute myeloid leukemia, Myelodysplastic syndromes
Company intelligence / Profile preview
Laboratorio Varifarma S.A. is an active private pharmaceutical company founded in Argentina in the mid-'90s. It specializes in developing and commercializing high-quality medicines for oncology, hematology, transplantation cases, rare diseases as well as other complex therapeutic areas such as neurology and HIV. The company has a strong presence throughout Latin America with partnerships spanning over fifteen international companies. Its portfolio includes both proprietary developments and licensed-in therapies—recent highlights include advanced prostate cancer treatment with Relugolix ("GORAX"), new breast cancer drugs under expansion plans, ADHD treatments entering the market segment for neurological disorders. The firm regularly participates in major medical congresses to showcase clinical results.[1][2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorio Varifarma.